Clinical trial NCT03036982: Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma
Official title: Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Asthma
Lead sponsor: Boston Children's Hospital
Sponsor class: OTHER
First posted: 2017-01-31
Enrollment: 221
Sex: ALL
Minimum age (years): 4
Maximum age (years): 21
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients with asthma seen in one of the clinics caring for patients with asthma at Boston Children's Hospital Age 4-21

Brief summary: This study will assess whether adaption of the Asthma Control Test (ACT) and childhood Asthma Control Test (cACT) for mobile devices improves rate of completion and improves control of asthma in children and adolescents

Detailed description: Asthma is the most prevalent chronic disease of childhood with an overall prevalence of 10%. While effective therapies exist to control symptoms and prevent exacerbations, many asthma patients experience significant morbidity including limitations on daily activities as well as asthma exacerbations that lead to missed school (and work for care givers) and necessitate emergency department visits and hospitalizations. Among children from lower socioeconomic statues and in black and Hispanic families, asthma incidence and severity are even greater. Reasons for this disparity included decreased access to effective asthma care, increased exposure to tobacco smoke and environmental allergens, and underutilization of controller medicines. These groups have significantly increased resource utilization due to emergency department visits and hospitalizations. Optimal care for asthma patients, especially those with at highest risk, will therefore require new strategies for evaluating ongoing control and providing direct feedback to patients.

We propose to transform the way asthma care is provided through the use of an innovative patient centered technology -Trivox Asthma - to improve quality of care and outcomes for asthma patients while reducing the cost of care. Specifically we will extend Trivox Health to facilitate closer monitoring of patients with asthma through the existing web platform and a new mobile interface. This will allow asthma patients, their parents and school nurses to remotely input data on asthma control through smartphones and/or tablets. We will use the ACT+, an expansion of a validated measure currently utilized in both primary care and specialty clinics, to measure both asthma control and risk.

Effectiveness of this intervention will be measured by examining resource utilization and ongoing asthma control.

Eligibility criteria: Inclusion Criteria:

* Diagnosis of asthma
* Cared for at Boston Children's Hospital (Primary or secondary care)

Exclusion Criteria:

* Age \<4 or \>21

Primary outcomes:
measure: Well-controlled asthma
timeFrame: Each month for one calendar year
Secondary outcomes:
measure: Asthma Emergency Department visits and hospitalizations
timeFrame: Total Emergency Department Visits and hospitalizations with asthma as one of top diagnosis in one year
Other outcomes:
Locations:
city: Boston
country: United States
facility: Boston Childrens Hospital
state: Massachusetts
Study officials:
affiliation: Boston Children's Hosptial
name: Andrew MacGinnitie, MD PhD
role: PRINCIPAL_INVESTIGATOR
References: